Olin's financial performance reflects a robust business model, with its Chlor Alkali Products and Vinyls segment contributing 54% to sales, the Epoxy segment accounting for 20%, and the Winchester segment underpinning the company's strong presence in the ammunition market. The Winchester business acts as a counterbalance to commodity cycles in chemicals, offering product diversification. The company operates with established manufacturing infrastructure and a diversified customer base spanning commercial industries and government agencies.
Cyborg Score Rationale
Olin demonstrates solid fundamentals with diversified revenue streams across stable chemical commodities and branded Winchester ammunition. However, the company faces commodity price cyclicality, regulatory risks in chemical manufacturing, and environmental compliance challenges that limit upside potential.
Top Insights
Chlor Alkali and Vinyls segment drives majority revenues at 54% of sales, with Epoxy at 20% and Winchester ammunition at remainder, providing diversification.
Chemical segments are sensitive to commodity price swings; changes in global supply/demand for chlorine derivatives or feedstock costs can materially affect margins and cash flow.
Company demonstrates commitment to R&D investment, positioning it to innovate and develop new products, which can enhance competitive advantage and open market opportunities.
With significant market value of approximately $2.3 billion and a substantial backlog of orders, Olin stands as a formidable player in its respective markets.
Named Competitors
Dow Chemical/Chlorine & Epoxy — Global chemical giant with chlorine, epoxy and vinyl operations
Chlor-Alkali & Vinyls — Integrated petrochemical and vinyl manufacturer
Sporting Ammunition — Leading U.S. ammunition and outdoor products manufacturer
Industrial Chemicals — Specialty and commodity chemicals producer
Recent Developments
(February 2026) Olin filed its 10-K report for fiscal year ended December 31, 2025, filed on February 20, 2026.
(2025) Chlor Alkali and chemical segments maintained core operations with 54% revenue contribution; Winchester ammunition business remained stable cash generator.
(2024) Revenue declined 4.3% to $6.5B in 2024 versus 2023; net income fell 76.4% due to margin pressures.
Open the full interactive Olin Corporation report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.